Speaker Profile

Pioneering work in cancer immunotherapy, including the development of adoptive T cell therapies for solid tumors and groundbreaking cancer vaccine trials.

M.D., Ph.D., Director, Ludwig Inst. for Cancer Research

Dr. George Coukos, a leading figure in tumor immunology, serves as the director of the Lausanne Branch of the Ludwig Institute for Cancer Research and the Department of Oncology at the University of Lausanne in Switzerland. His pioneering work presently focuses on developing precision immunotherapy in cancer treatment, particularly in Tcell therapies. Notably, he's been instrumental in developing personalised immunotherapies, including an autologous dendritic cell vaccine and adoptive Tcell therapy with vaccineprimed autologous Tcells for ovarian cancer treatment.Dr. Coukos's research has unveiled the spontaneous antitumor response in ovarian cancer, challenging previous beliefs and expanding its application beyond ovarian to other solid tumors. He's also elucidated critical mechanisms governing the interplay between tumors and the immune system, including the role of the tumor vasculature in erecting a barrier to T cell trafficking in tumors. His translational efforts have led to significant clinical advancements, and he continues to lead groundbreaking trials in the field. Dr. Coukos is at the forefront of precision oncology, leveraging advanced technologies like highthroughput sequencing to tailor immunotherapies based on molecular and genetic specifics of the tumor cells and the tumor microenvironment. His research pursuits of innovative therapies have set new standards in cancer immunotherapy, including the recent development of rational engineering of superior effector T cell states for adoptive therapy.

 Session Abstract – PMWC 2024 Silicon Valley

Track 1 - January 25 9.00 A.M.-3.00 P.M.

Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2024 Award Ceremony
    Pioneer Honoree: Stanley Riddell, Fred Hutchinson
    Pioneer Honoree: George Coukos, Ludwig Cancer Center
  • Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
    Chair: Harlan Robins, Adaptive Bio
    - Stanley Riddell, Fred Hutchinson
    - Allison Betof Warner, Stanford
  • Evolving Case Law and Practical Strategies for Immunotherapy Patents
    - Janet Xiao, Morrison & Foerster LLP
  • Scientific Advancements in Individualized Cell Therapeutics for Oncology( PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - George Coukos, Ludwig Institute for Cancer Research
    - Bobert Meehan, Moderna
  • Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
    Chair: TBA
    - Amanda Pace, Sonoma Bio
  • AI-Enhanced Approaches in Gene-Modified Cell Therapy Development
    Chair: TBA
    - Brian Weitzner, Outpace Bio
    - Richard Bonneau, Prescient Design


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by SEP. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required